Transaction Overview - Beijing Jinchengzi Technology Co., Ltd. (hereinafter referred to as "the company" or "Jinchengzi") approved the sale of a 15% stake in Suzhou Kamenhas Laser Technology Co., Ltd. for a total consideration of RMB 75 million during its board meeting on December 2, 2025 [2] - The stake being sold represents a registered capital of RMB 4.1667 million in Kamenhas [2] Progress of the Transaction - As of December 3, 2025, the company has signed the "Equity Transfer Agreement" with multiple parties, including Xu Haijian, Xu Haifeng, Guo Yonghua, and Zhou Zhikai [3] - According to the agreement, a total of RMB 35 million is to be paid within 30 days of the agreement's effectiveness, with specific amounts allocated to each party [4] - The company has received RMB 21 million from Xu Haijian, Guo Yonghua, and Zhou Zhikai, while Xu Haifeng has yet to pay his share of RMB 14 million [4] - Xu Haifeng has committed to arranging the necessary funds to fulfill his payment obligations and will pay any penalties for late payment as stipulated in the agreement [4] Impact on Company Operations - The outstanding payment from Xu Haifeng is not expected to significantly impact the company's daily operations [5] - The company will take necessary measures based on the actual situation and will fulfill its disclosure obligations in accordance with relevant laws and regulations [5] Investor Advisory - The transaction involves multiple counterparties and a lengthy payment cycle, which introduces the risk of non-payment by the counterparties [6]

每经头条（nbdtoutiao）——最高返现60%！惠民保年末销售乱象调查：业务员"贴钱"冲考核，谁在"赔 本赚吆喝"？ 每经AI快讯，汉威科技12月31日晚间发布公告称，为进一步优化资源配置和产业布局，公司根据战略 发展规划，拟将持有的控股子公司广东龙泉26%的股权以152.19万元的价格转让给弋要争。本次交易完 成后，公司持有广东龙泉25%的股权，广东龙泉将不再纳入公司合并报表范围。 （记者 贾运可） ...

汉威科技公告，为进一步优化资源配置和产业布局，公司拟将持有的控股子公司广东龙泉科技有限公司 26%的股权以152.19万元的价格转让给弋要争。交易完成后，公司持有广东龙泉的股权比例将由51%下 降至25%，广东龙泉不再纳入公司合并报表范围。 ...

科森科技公告称，公司曾于2025年12月拟向耀岭科出售全资子公司科森医疗100%股权，交易金额9.15 亿元。2025年已收到股权转让款455,221,420.20元，与首期款相差2,278,579.80元，交易对方将在2026年1 月补足，剩余价款在完成工商变更15个工作日内支付。目前，相关交割手续仍在办理，无法在2025年12 月31日前完成全部交割。本次交易预计增加公司2026年度投资收益约6亿元，交易完成后，公司不再持 有科森医疗股权。 ...

Core Viewpoint - The company has successfully completed the sale of 100% equity in Jian Architecture and its design business assets, receiving a total of 157.49 million yuan for the equity transfer and 39.6886 million yuan for 20% of the asset package transfer [1] Group 1 - The company has received the full payment of 157.49 million yuan for the equity transfer [1] - The company has also received 20% of the asset package transfer payment, amounting to 39.6886 million yuan [1] - Future updates regarding the remaining asset transfer payments will be disclosed in a timely manner [1] Group 2 - The company has proposed a restricted stock incentive plan for 2025, intending to grant 5 million restricted shares to 21 incentive recipients [1] - The restricted shares will vest in two installments after a 12-month period, with each installment representing 50% of the total shares [1]

Group 1 - ST Bailing announced that Hainan Hongtian received an execution payment of 170 million yuan, which has been fully executed and will conclude on December 24, 2025 [1] - The remaining funds after deducting recovery costs and related expenses will be used to transfer the company's remaining 36% stake in Beijing Hongtian [1] - A framework agreement for the equity transfer was signed on December 29, 2025, among the involved parties, agreeing that Detianhou Company will acquire the remaining 36% stake [1] Group 2 - The final transaction price is currently undetermined due to several pending cases, including a 146 million yuan case with no received execution payment and a 150 million yuan case still under trial [1] - There is a risk that the effectiveness of the 170 million yuan case's judgment could be revoked if the other two cases do not yield favorable outcomes, which may affect the determination of the transaction price [1] - An agreement was made for Detianhou Company to pay 65 million yuan as a good faith deposit for the equity transfer within three days of signing the agreement [2]

Core Viewpoint - The company plans to optimize its resource allocation by transferring its 33.409% stake in China Oceanwide Fund Management Co., Ltd. through a public listing and joint transfer with France's Rothschild Bank [1] Group 1: Transfer Details - The joint transfer will involve a total of 58.409% of the shares in China Oceanwide Fund, requiring the buyer to acquire both the company's and Rothschild Bank's stakes [1] - The initial listing price for the company's 33.409% stake will not be lower than the assessment results approved by state-owned assets [1] Group 2: Shareholding Structure - China Oceanwide Fund is a public fund management company in which the shareholding structure is as follows: China Oceanwide Trust Co., Ltd. holds 41.591%, the company holds 33.409%, and Rothschild Bank holds 25.000% [1] - After the transfer is completed, the company will no longer hold any shares in China Oceanwide Fund [1]

Core Viewpoint - Guolian Minsheng (601456.SH) announced a strategic move to optimize resource allocation by transferring its 33.409% stake in Zhonghai Fund through a public listing and joint transfer with France's Rothschild Bank, which holds a 25% stake [1] Group 1: Company Structure - Zhonghai Fund's ownership structure includes Zhonghai Trust holding 41.591%, Guolian Minsheng holding 33.409%, and Rothschild Bank holding 25% [1] Group 2: Transfer Details - The joint transfer of shares will total 58.409%, requiring the buyer to acquire both Guolian Minsheng's and Rothschild Bank's stakes in Zhonghai Fund [1] - The initial listing price for the 33.409% stake will not be lower than the evaluation results approved by state-owned assets [1] - There is uncertainty regarding the final transaction price and the identity of the buyer [1]

Core Viewpoint - ST Haofeng (300419.SZ) announced the sale of its wholly-owned subsidiary Huayuan Zhide to optimize its asset structure and improve operational efficiency [1] Group 1 - The company signed a share transfer agreement with Cheng Xueyong on December 29, 2025, to sell 100% equity of Huayuan Zhide for a cash consideration of 1 million yuan [1] - Following the completion of this transaction, the company will no longer hold any shares in Huayuan Zhide, and Huayuan Zhide will be excluded from the company's consolidated financial statements [1]

Core Viewpoint - Jinjiang Hotels plans to transfer its entire equity holdings in Shanghai Jichangkun, Shanghai Huailian, Shanghai Ehan Kun, and Shanghai Liaokun to Jinjiang Capital through a private agreement for a total price of 207 million RMB [1] Group 1 - The equity transfer will result in Jinjiang Hotels' wholly-owned subsidiary, Shanghai Jinjiang International Hotel Investment Co., Ltd., signing lease agreements with the four companies for their properties to be used for hotel operations [1]